Tachyphylaxis to β2-agonists in Spanish asthmatic patients could be modulated by β2-adrenoceptor gene polymorphisms

Respiratory Medicine

Volumn 100, Issue 6, 2006, Pages 1072-1078

  Tellería, Juan Jose ^a   Blanco Quirós, Alfredo ^a   Muntión, Sandra ^a   Antonio Garrote, Jose ^a,c   Arranz, Eduardo ^a   Armentia, Alicia ^b   Díez, Ignacio ^c   Castro, Jesús ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

2 adrenoceptor; 2AR; Alleles; Asthma; Polymorphisms; Tachyphylaxis

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; GLUTAMINE; GLYCINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ADOLESCENT; ADULT; ALLELE; ARTICLE; ASTHMA; BLOOD DONOR; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIZATION; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPAIN; STATISTICAL SIGNIFICANCE; TACHYPHYLAXIS; TREATMENT OUTCOME; DRUG ADMINISTRATION; GENETICS; INHALATION TEST; MIDDLE AGED; TREATMENT FAILURE;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; ALLELES; ASTHMA; BRONCHIAL PROVOCATION TESTS; CASE-CONTROL STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTORS, ADRENERGIC, BETA-2; TACHYPHYLAXIS; TREATMENT FAILURE;

EID: 33645800240     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.09.028     Document Type: Article

References (26)

1. 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 8 3 (1993) 334-339
2. Drazen J.M., Silverman E.K., and Lee T.H. Heterogeneity of therapeutic responses in asthma. Br Med Bull 56 4 (2000) 1054-1070
3. 16 correlates with the nocturnal phenotype. J Clin Invest 95 4 (1995) 1635-1641
4. 2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families. J Allergy Clin Immunol 100 2 (1997) 261-265
5. 2-adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers. Thorax 58 8 (2003) 703-707
6. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 100 12 (1997) 3184-3188
7. Erickson R.P., and Graves P.E. Genetic variation in β-adrenergic receptors and their relationship to susceptibility for asthma and therapeutic response. Drug Metab Dispos 29 4 Part 2 (2001) 557-561
8. 2-adrenergic receptor haplotypes alter receptor expression and predict "in vivo" responsiveness. Proc Natl Acad Sci USA 97 19 (2000) 10483-10488
9. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136 (1987) 225-244
10. American Thoracic Society. Standarization of spirometry. Update. Am J Respir Crit Care Med 152 (1994) 1107-1136
11. Cockcroft D.W., McParland C.P., Britto S.A., Swystum V.A., and Rutherford B.C. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 342 8875 (1993) 833-837
12. Balding D.J., Bishop M., and Cannings C. Handbook of statistical genetics (2001), Wiley, Chichester
13. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., and Poland G.A. Score tests for association of traits with haplotypes when linkage phase is ambiguous. Am J Hum Genet 70 (2002) 425-434
14. 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 84 1 (1987) 46-50
15. 2-adrenoceptor gene. Chest 121 3 (2002) 722-731
16. 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics. Lancet 350 9083 (1997) 995-999
17. 2-adrenoceptor on desensitization in human lung mast cells. Pharmacogenetics 10 2 (2000) 153-162
18. Harvey J.E., and Tattersfield A.E. Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax 37 (1982) 280-287
19. Tashkin D.P., Conolly M.E., Deutsch R.I., et al. Subsensitization of the beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjects. Am Rev Respir Dis 125 (1982) 185-193
20. Lipworth B.J., Struthers A.D., and McDevitt D.G. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbultamol in asthmatics. Am Rev Respir Dis 140 (1989) 586-592
21. Larsson S., Svedmyr N., and Thiringer G. Lack of bronchial adrenoceptor resistance in asthmatics during long-term treatment with terbutaline. J Allergy Clin Immunol 59 (1977) 93-100
22. van Schayck C.P., Graafsma S.J., Visch M.B., et al. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 yr is not caused by subsensitization to salbutamol. J Allergy Clin Immunol 96 (1990) 793-800
23. Gibson G.J., Greenacre J.K., König P., et al. Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma. Br J Dis Chest 72 (1978) 199-206
24. Vathenen A.S., Knox A.J., Higgens B.G., Britton J.R., and Tattersfield A.E. Rebound increased in bronchial hyperresponsiveness after treatment with inhaled terbutaline. Lancet 1 (1988) 554-558
25. 2-agonists in asthma. N Engl J Med 327 (1992) 1204-1208
26. Barnes P.J. Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 152 (1995) 838-860